while hgsi has said to expect results of the 52 week trial in july, the reality is we could get news on the trial at any time now since the trial was completed in april. it would not be unusual for data to be released well before july. the july date was chosen as the maximum outside date that would be needed to analyze and compile the data. the reality is that the data monitoring committee has been looking at the data throughout the trial and in all likely hood already knows the outcome.
with that said we could get an announcement of preliminary results at any point now. early releases happen all the time in trials. it is interesting to note that unlike the recent la jolla riquent trial hgsi's 52 week trial was not stopped early because the committee did not see any benefit.
the fact there could be bad news is a beautiful thing. that is why the stock is at 1.82. the stock has failure priced. if it fails maybe we trade down to a dollar, but if it successful we could 10+. i have also seen the doctor who has been posting on this board for 10 years and generally negative on the stock put the odds of success around 40%.
i like this whole risk reward scenario. 40% chance of success and if successful up 8-10 point. if not successful down 1 point. everyone should have room in their portfolio for that type of flier. not to mention if you throw in an additional abthrax order and/or positive hepititis news you could be looking at a 20+ stock.
also, check out this seeking alpha article about big money rotation into biotech. most popular article on seeking alpha right now: